Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Lenalidomide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 33 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, Follicular 11 Lymphoma, B-Cell, Marginal Zone 6 Neoplasms, Plasma Cell 5 Lymphoma 5 Recurrence 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neuroblastoma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Smoldering Multiple Myeloma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Leukemia, Hairy Cell 1 Hematologic Diseases 1 HTLV-I Infections 1 GATA2 Deficiency 1 Disease Progression 1 Composite Lymphoma 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

apalutamide 24 Magnetic Resonance Spectroscopy 24 Specimen Handling 20 enzalutamide 18 Abiraterone Acetate 18 Prednisone 15 Pluvicto 15 Radiosurgery 14 Androgen Antagonists 14 darolutamide 13 Docetaxel 12 Leuprolide 10 Biopsy 9 Triptorelin Pamoate 7 Radiotherapy 7 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 7 relugolix 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Surveys and Questionnaires 6 Standard of Care 6 Nivolumab 6 Goserelin 6 Educational Status 6 cabazitaxel 5 bicalutamide 5 abiraterone 5 Radiation 5 Glutamate Carboxypeptidase II 5 Carboplatin 5 gallium 68 PSMA-11 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡